Диссертация (1174337), страница 27
Текст из файла (страница 27)
– 2017. - Vol. 36. - № 5. - P. 259-270.24. Anand,M.IgA-DominantAcutePostinfectiousGlomerulonephritisPresenting as Acute Renal Failure in a Kidney Transplant Recipient / M. Anand,J.P. Arroyo, H. Alhalabi et al. // Kidney Int. Rep. - 2017. - Vol.
2. - № 4. - P. 766-769.25. Anders, H.J. Activation of toll-like receptor-9 induces progression of renaldisease in MRL-Fas(lpr) mice / H.J. Anders, V. Vielhauer, V. Eis et al. // FASEB J. 2004. - Vol. 18. - P. 534-536.26. Anders,H.J.BacterialCpG-DNAaggravatesimmunecomplexglomerulonephritis: role of TLR9-mediated expression of chemokines and chemokinereceptors / H.J. Anders, B. Banas, Y. Linde et al. // J. Am. Soc.
Nephrol. - 2003. Vol. 14. - P. 317-326.16227. Anders, H.J. Beyond tissue injury-damage-associated molecular patterns, tolllike receptors, and inflammasomes also drive regeneration and fibrosis / H.J. Anders,L. Schaefer // J. Am. Soc. Nephrol. 2014. - Vol. 25. - P. 1387–1400.28. Anders, H.J. Of Inflammasomes and Alarmins: IL-1β and IL-1α in KidneyDisease / H.J. Anders// J. Am. Soc. Nephrol.– 2016. - Vol. 27.
- № 9. -P. 2564-2575.29. Anderson, S. Current concepts of renal hemodynamics in diabetes/ S. Anderson, J.P. Vora // J. Diabetes Complications. - 1995. - Vol. 9. - № 4. - P. 304307.30. Arango Duque G. Macrophage cytokines: involvement in immunity andinfectious diseases / G. Arango Duque, A. Descoteaux // J.Front. Immunol. - 2014. Vol. 5. – Р.
491.31. Atkins, R.C. The epidemiology of chronic kidney disease / R.C. Atkins// Kidney Int. - 2005. - Vol. 67. - № 94. - P. 14-18.32. Atkinson, C. Low-dose targeted complement inhibition protects against renaldisease and other manifestations of autoimmune disease in MRL/lpr mice / C. Atkinson,F. Qiao, H. Song et al. // J.
Immunol. - 2008. - Vol. 180. - P. 1231–1238.33. Attridge, K. Homeostasis and function of regulatory T cells (Tregs) in vivo:Lessons from TCR-transgenic Tregs / K. Attridge, L.S. Walker // Immunol. Rev. - 2014.- Vol. 259. - № 1. - P. 23–39.34. Vent-Schmidt, J. The role of FOXP3 in regulating immune responses / J.Vent-Schmidt, J.M. Han, K.G. MacDonald, M.K. Levings // Int. Rev. Immunol. - 2014.- Vol.
33. - № 2. - P. 110–128.35. Ayodele, O.E. Burden of chronic kidney disease: an international perspective/ O.E. Ayodele, C.O. Alebiosu // Adv. Chronic Kidney Dis. - 2010. - Vol. 17. P. 215-224.36. Bai, J. Suppressor of Cytokine Signaling-1/STAT1 Regulates RenalInflammation in Mesangial Proliferative Glomerulonephritis Models / J. Bai, L. Wu, X.Chen et al. // Front.
Immunol. - 2018. - Vol. 9. - P. 1982.16337. Bakr, A. Tumor necrosis factor-alpha production from mononuclear cells innephrotic syndrome / A. Bakr, M. Shokeir, F. El-Chenawi et al. // Pediatr. Nephrol. 2003. - Vol. 18. - № 6. - P. 516-520.38. Balow, J. E. Kidney disease in systemic lupus erythematosus / J. E. Balow// Rheumatol. Int. - 1991. - Vol. 11. - P. 113–115.39. Batal, I. Glomerular inflammation correlates with endothelial injury and withIL-6 and IL-1β secretion in the peripheral blood / I. Batal, S.A. De Serres, B.G. Mfarrejet al.
// Transplantation. - 2014. - Vol. 97. - № 10. - P. 1034-1042.40. Beal, A.L. Multiple organ failure syndrome in the 1990s. Systemicinflammatory response and organ dysfunction / A.L. Beal, F.B. Cerra // JAMA. - 1994.- Vol. 271. - № 3. - P. 226-233.41. Beck, L.H. Jr. M-type phospholipase A2 receptor as target antigen inidiopathic membranous nephropathy / L.H.
Beck Jr., R.G. Bonegio, G. Lambeau et al.// N. Engl. J. Med. 2009. - Vol. 361. - № 1. - P. 11-21.42. Berger, S.P. Complement in glomerular injury / S.P. Berger, M.R. Daha// Semin. Immunopathol. - 2007. - Vol. 29. - P. 375–384.43. Berthoux,F. Autoantibodies targeting galactose-deficient IgA1 associatewith progression of IgA nephropathy / F. Berthoux, H. Suzuki, L. Thibaudin et al.// J. Am.
Soc. Nephrol. - 2012. - Vol. 23. – Р. 1579–1587.44. Besbas, N. Monocyte chemoattractant protein-1 and interleukin-8 levels inchildren with acute poststreptococcal glomerulonephritis / N. Besbas, F. Ozaltin,F. Catal et al. // Pediatr. Nephrol. - 2004. - Vol. 19. - P. 864–868.45. Bomback, A.S. Complement-Mediated Glomerular Diseases: A Tale of 3Pathways /A.S. Bomback, G.S. Markowitz, G.B. Appel // Kidney Int. Rep. - 2016.
Vol. 1. - № 3. - P. 148-155.46. Brähler, S. Opposing Roles of Dendritic Cell Subsets in Experimental GN/ S. Brähler, B.H. Zinselmeyer, S. Raju et al. // J. Am. Soc. Nephrol. - 2017. - Vol. 29. № 1. - P. 138-154.16447. Buckner,J.H.MechanismsofimpairedregulationbyCD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases/ J.H. Buckner // Nat. Rev. Immunol. - 2010.
- Vol. 10. - № 12. - P. 849-859.48. Caramalho, I. Regulatory T Cells Selectively Express Toll-like Receptors andAre Activated by Lipopolysaccharide / I.Caramalho, T. Lopes-Carvalho, D. Ostler etal. // The Journal of Experimental Medicine. - 2003. - Vol. 197. - № 4. - P. 403-411.49. Carapetis, J.R. The global burden of group A streptococcal diseases/ J.R. Carapetis, A.C. Steer, E.K.
Mulholland et al. // Lancet Infect. Dis. - 2005. - Vol. 5.- P. 685–694.50. Chadban, S.J.Interleukin-10 differentially modulates MHC class IIexpression by mesangial cells and macrophages in vitro and in vivo / S.J. Chadban,G.H. Tesch, R. Foti et al. // Immunology. - 1998. - Vol. 94. - № 1. - P. 72-78.51. Chadban, S.J. Glomerulonephritis / S.J. Chadban, R.C. Atkins // Lancet.
2005. - Vol. 365. - P. 1797.52. Chandler, C.E. Bacterial lipids: powerful modifiers of the innate immuneresponse / C.E. Chandler, R.K. Ernst // F 1000 Research. - 2017. - Vol. 6. - P. 1334.53. Chávez, V. V. Epidemiology of glomerular disease in adults: a databasereview / V. V. Chávez, C.C. Orizaga, F.J.G.Becerra et al. // Gac. Med.
Mex. – 2014. Vol. 150. - № 5. - P. 403-408.54. Chen, A. Interleukin-1 receptor antagonist modulates the progression of aspontaneously occurring IgA nephropathy in mice / A. Chen, L.F. Sheu, W.Y. Chou etal. // Am. J. Kidney Dis. - 1997. - Vol. 30. - № 5. - P. 693–702.55. Chen, W.Y.
Emerging Roles of IL-33/ST2 Axis in Renal Diseases/ W.Y. Chen, L.C. Li, J.L. Yang // Int. J. Mol. Sci. - 2017. - Vol. 18. - № 4. - P. 783.56. Chen, X. Acute postinfectious glomerulonephritis with a large number ofcrescents caused by Mycoplasma pneumoniae / X. Chen, W. Xu, J. Du et al. // IndianJ. Pathol. Microbiol. – 2015. – Vol. 58.
- № 3. – P. 374-376.57. Chen, X. Toll-like receptor 4 is involved in a protective effect of rhein onimmunoglobulin A nephropathy / X. Chen, S. Peng, H. Zeng et al. // Indian Journal ofPharmacology. - 2015. - Vol. 47. - № 1. - P. 27-33.16558. Cho, B.S. Upregulation of interleukin-4 and CD23/Fc epsilon RII in minimalchange nephrotic syndrome / B.S. Cho, S.R. Yoon, J.Y. Jang et al.
// Pediatr. Nephrol. 1999. - Vol. 13. - № 3. - P. 199–204.59. Cochrane, C.G. Immune complex disease in experimental animals and man /C.G. Cochrane, D. Koffler // Adv. Immunol. - 1973. - Vol. 16. - P. 185-264.60. Colin, E.M. 1,25-dihydroxyvitamin D3 modulates Th17 polarization andinterleukin-22 expression by memory T cells from patients with early rheumatoidarthritis / E.M. Colin, P.S. Asmawidjaja, J.P.
van Hamburg et al. // Arthritis Rheum. 2010. - Vol. 62. - № 1. - P. 132–42.61. Couser, W.G. Basic and Translational Concepts of Immune-MediatedGlomerular Diseases / W.G. Couser // J. Am. Soc. Nephrol. - 2012. - Vol. 23. - № 3. P. 381-399.62. Couser, W.G. Pathogenesis and treatment of glomerulonephritis – an update/ W.G. Couser // J. Bras. Nefrol. - 2016. - Vol. 38. - № 1.
- P. 107-122.63. Couser, W.G. Pathogenesis of glomerular damage in glomerulonephritis/ W.G. Couser // Nephrol. Dial. Transplant. - 1998. - Vol. 13. - P. 10–15.64. Couser, W.G. Primary Membranous Nephropathy / W.G. Couser // Clin. J.Am. Soc. Nephrol. - 2017. - Vol. 12. - № 6.
- P. 983-997.65. Cronkite, D.A. The Regulation of Inflammation by Innate and AdaptiveLymphocytes / D.A. Cronkite, T.M. Strutt // J. Immunol. Res. - 2018; 2018:1467538.Published online 2018 Jun 11. doi: 10.1155/2018/1467538.66. D'Agati, V.D. Pathologic classification of focal segmental glomerulosclerosis:a working proposal / V.D. D'Agati, A.B. Fogo, J.A.